Pulmonary veno-occlusive disease following hematopoietic stem cell transplantation: a rare model of endothelial dysfunction

Bone Marrow Transplant. 2008 Apr;41(8):677-86. doi: 10.1038/sj.bmt.1705990. Epub 2008 Jan 28.


Veno-occlusive disease is among the most serious complications following hematopoietic stem cell transplantation. While hepatic veno-occlusive disease occurs more commonly, the pulmonary variant remains quite rare and often goes unrecognized antemortem. Endothelial damage may represent the pathophysiologic foundation of these clinical syndromes. Recent advances in the treatment of hepatic veno-occlusive disease may have application to its pulmonary counterpart.

Publication types

  • Review

MeSH terms

  • Endothelium / physiology*
  • Fibrinolytic Agents / therapeutic use
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Polydeoxyribonucleotides / therapeutic use
  • Pulmonary Veno-Occlusive Disease / etiology
  • Pulmonary Veno-Occlusive Disease / physiopathology*


  • Fibrinolytic Agents
  • Polydeoxyribonucleotides
  • defibrotide